Cargando…
Genetic Influences in Breast Cancer Drug Resistance
Breast cancer is the most common cancer in adult women aged 20 to 50 years. The therapeutic regimens that are commonly recommended to treat breast cancer are human epidermal growth factor receptor 2 (HER2) targeted therapy, endocrine therapy, and systemic chemotherapy. The selection of pharmacothera...
Autores principales: | Daniyal, Adhitiya, Santoso, Ivana, Gunawan, Nadira Hasna Putri, Barliana, Melisa Intan, Abdulah, Rizky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882715/ https://www.ncbi.nlm.nih.gov/pubmed/33603458 http://dx.doi.org/10.2147/BCTT.S284453 |
Ejemplares similares
-
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy
por: Fahira, Alistia Ilmiah, et al.
Publicado: (2022) -
Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine
por: Barliana, Melisa Intan, et al.
Publicado: (2022) -
Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy
por: Ausi, Yudisia, et al.
Publicado: (2021) -
Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
por: Afifah, Nadiya Nurul, et al.
Publicado: (2020) -
Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors
por: Witka, Beska Z, et al.
Publicado: (2019)